
No. of Pages: 116 | Report Code: TIPRE00020960 | Category: Life Sciences
No. of Pages: 116 | Report Code: TIPRE00020960 | Category: Life Sciences
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 South and Central America Neurological Biomarker Market – By Product
1.3.2 South and Central America Neurological Biomarker Market – By Application
1.3.3 South and Central America Neurological Biomarker Market – By End User
1.3.4 South and Central America Neurological Biomarker Market – By Country
2. Neurological Biomarker Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Neurological Biomarker Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 South & Central America
4.3 Expert Opinion
5. Neurological Biomarker Market – Key Market Dynamics
5.1 Key Market Drivers
5.1.1 Rising Prevalence of Neurological Diseases
5.1.2 Growing Focus on Neurological Biomarker Research
5.2 Key Market Restraints
5.2.1 Concerns Associated with Biomarkers
5.3 Key Market Opportunities
5.3.1 Increasing Awareness of Neurological Diseases Coupled with Developing Healthcare Infrastructure
5.4 Future Trends
5.4.1 The Rising Trend of Precision/Personalized Healthcare
5.5 Impact analysis
6. Neurological Biomarker Market – South and Central America Analysis
6.1 South and Central America Neurological Biomarker Market Revenue Forecast and Analysis
7. Neurological Biomarker Market Analysis– by Product
7.1 Overview
7.2 Neurological Biomarker Market Share, By Product, 2019 & 2027 (%)
7.3 Proteomics Biomarker
7.3.1 Overview
7.3.2 Proteomics Biomarker Market Revenue and Forecasts to 2027 (US$ Mn)
7.4 Genomics Biomarker
7.4.1 Overview
7.4.2 Genomics Biomarker Market Revenue and Forecasts to 2027 (US$ Mn)
7.5 Metabolomics Biomarker
7.5.1 Overview
7.5.2 Metabolomics Biomarker Market Revenue and Forecasts to 2027 (US$ Mn)
7.6 Imaging Biomarker
7.6.1 Overview
7.6.2 Imaging Biomarker Market Revenue and Forecasts to 2027 (US$ Mn)
7.7 Others
7.7.1 Overview
7.7.2 Others Market Revenue and Forecasts to 2027 (US$ Mn)
8. Neurological Biomarker Market Analysis– by Application
8.1 Overview
8.2 Neurological Biomarker Market Share, By Application, 2019 & 2027 (%)
8.3 Alzheimer’s Disease
8.3.1 Overview
8.3.2 Alzheimer’s Disease Market Revenue and Forecasts to 2027 (US$ Mn)
8.4 Parkinson’s Disease
8.4.1 Overview
8.4.2 Parkinson’s Disease Market Revenue and Forecasts to 2027 (US$ Mn)
8.5 Schizophrenia
8.5.1 Overview
8.5.2 Schizophrenia Market Revenue and Forecasts to 2027 (US$ Mn)
8.6 Huntington's Disease
8.6.1 Overview
8.6.2 Huntington's Disease Market Revenue and Forecasts to 2027 (US$ Mn)
8.7 Spinal Muscular Atrophy
8.7.1 Overview
8.7.2 Spinal Muscular Atrophy Market Revenue and Forecasts to 2027 (US$ Mn)
8.8 Others
8.8.1 Overview
8.8.2 Others Market Revenue and Forecasts to 2027 (US$ Mn)
9. Neurological Biomarker Market Analysis– by End User
9.1 Overview
9.2 Neurological Biomarker Market Share, By End User, 2019 & 2027 (%)
9.3 Pharmaceutical and Biotechnology Companies
9.3.1 Overview
9.3.2 Pharmaceutical and Biotechnology Companies Market Revenue and Forecasts to 2027 (US$ Mn)
9.4 Clinical Diagnostics
9.4.1 Overview
9.4.2 Clinical Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
9.5 Research Organizations
9.5.1 Overview
9.5.2 Research Organizations Market Revenue and Forecasts to 2027 (US$ Mn)
10. Neurological Biomarker Market Analysis and Forecasts To 2027 – Geographical Analysis
10.1 South and Central America: Neurological Biomarker Market
10.1.1 Overview
10.1.2 South and Central America: Neurological Biomarker Market - Revenue and Forecast to 2027(US$ Million)
10.1.3 South and Central America: Neurological Biomarker Market, by Product, 2018–2027 (USD Million)
10.1.4 South and Central America: Neurological Biomarker Market, by Application, 2018–2027 (USD Million)
10.1.5 South and Central America: Neurological Biomarker Market, by End User, 2018–2027 (USD Million)
10.1.6 South and Central America: Neurological Biomarker Market, by Country, 2019 & 2027 (%)
10.1.7 Brazil: Neurological Biomarker Market – Revenue and Forecast to 2027 (USD Million)
10.1.7.1 Brazil: Neurological Biomarker Market – Revenue and Forecast to 2027 (USD Million)
10.1.7.2 Brazil: Neurological Biomarker Market, by Product, 2018–2027 (USD Million)
10.1.7.3 Brazil: Neurological Biomarker Market, by Application, 2018–2027 (USD Million)
10.1.7.4 Brazil: Neurological Biomarker Market, by End User, 2018–2027 (USD Million)
10.1.8 Argentina: Neurological Biomarker Market – Revenue and Forecast to 2027 (USD Million)
10.1.8.1 Argentina: Neurological Biomarker Market – Revenue and Forecast to 2027 (USD Million)
10.1.8.2 Argentina: Neurological Biomarker Market, by Product, 2018–2027 (USD Million)
10.1.8.3 Argentina: Neurological Biomarker Market, by Application, 2018–2027 (USD Million)
10.1.8.4 Argentina: Neurological Biomarker Market, by End User, 2018–2027 (USD Million)
11. Impact of COVID-19 Pandemic on South and Central America Neurological Biomarker Market
11.1 South and Central America: Impact Assessment of COVID-19 Pandemic
12. Company Profiles
12.1 Thermo Fisher Scientific Inc.
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Abbott
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Bio-Rad Laboratories Inc.
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 QIAGEN
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Immunarray Pvt. Ltd.
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Quest Diagnostics Incorporated
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Perkin Elmer, Inc.
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 MERCK KGaA
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
13. Appendix
13.1 Glossary of Terms
LIST OF TABLES
Table 1. South and Central America Neurological Biomarker Market, by Product – Revenue and Forecast to 2027(USD Million)
Table 2. South and Central America Neurological Biomarker Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 3. South and Central America Neurological Biomarker Market, by End User– Revenue and Forecast to 2027 (USD Million)
Table 4. Brazil Neurological Biomarker Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 5. Brazil Neurological Biomarker Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 6. Brazil Neurological Biomarker Market, by End User– Revenue and Forecast to 2027 (USD Million)
Table 7. Argentina Neurological Biomarker Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 8. Argentina Neurological Biomarker Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 9. Argentina Neurological Biomarker Market, by End User– Revenue and Forecast to 2027 (USD Million)
Table 10. Glossary of Terms, Neurological Biomarker Market
LIST OF FIGURES
Figure 1. Neurological Biomarker Market Segmentation
Figure 2. Neurological Biomarker Market – By Country
Figure 3. South and Central America Neurological Biomarker Market Overview
Figure 4. Genomic Biomarkers Segment Held Largest Share of Neurological Biomarker Market
Figure 5. South and Central America Neurological Biomarker Market- Leading Country Markets (US$ Million)
Figure 6. South & Central America PEST Analysis
Figure 7. Expert Opinion
Figure 8. Neurological Biomarker Market Impact Analysis of Driver and Restraint
Figure 9. South and Central America Neurological Biomarker Market – Revenue Forecast and Analysis – 2019- 2027
Figure 10. Neurological Biomarker Market Share, by Product, 2019 & 2027 (%)
Figure 11. Proteomics Biomarker Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 12. Genomics Biomarker Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 13. Metabolomics Biomarker Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 14. Imaging Biomarker Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 15. Others Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 16. Neurological Biomarker Market Share, by Application, 2019 & 2027 (%)
Figure 17. Alzheimer’s Disease Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 18. Parkinson’s Disease Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 19. Schizophrenia Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 20. Huntington's Disease Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 21. Spinal Muscular Atrophy Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 22. Others Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 23. Neurological Biomarker Market Share, by End User, 2019 & 2027 (%)
Figure 24. Pharmaceutical and Biotechnology Companies Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 25. Clinical Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 26. Research Organizations Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 27. South and Central America: Neurological Biomarker Market, by Key Country – Revenue (2019) (USD Million)
Figure 28. South and Central America Neurological Biomarker Market Revenue and Forecast to 2027 (USD Million)
Figure 29. South and Central America: Neurological Biomarker Market, by Country, 2019 & 2027 (%)
Figure 30. Brazil: Neurological Biomarker Market – Revenue and Forecast to 2027 (USD Million)
Figure 31. Argentina: Neurological Biomarker Market – Revenue and Forecast to 2027 (USD Million)
Figure 32. Impact of COVID-19 Pandemic in South and Central America Market